Skip to content

OABIW

OmniAb, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.16
−60.78%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue40.2M18.7M26.4M34.2M59.1M
Cost of Revenue14.6M22.1M———
Gross Profit25.5M(3.4M)26.4M34.2M59.1M
Operating Expenses
R&D Expense42.6M47.8M55.1M56.5M48.4M
SG&A Expense27.3M29.2M30.7M33.3M24.9M
General & Admin Expense27.3M29.2M30.7M33.3M24.9M
Selling & Marketing Expense—————
Other Expenses2.1M(8.8M)15.0M13.7M12.5M
Total Operating Expenses72.1M68.1M100.9M103.6M85.7M
Cost and Expenses86.7M90.2M100.9M103.6M85.7M
Operating Income (EBIT)(46.5M)(71.5M)(74.5M)(69.4M)(26.6M)
Non-Operating
Interest Income2.4M2.7M3.1M5.1M587.0K
Interest Expense—————
Net Interest Income2.4M2.7M3.1M5.1M587.0K
Other Non-Op Income/Expense2.2M5.2M3.1M5.1M587.0K
Non-Operating Income (excl Interest)(2.2M)(5.2M)(3.1M)(5.1M)(587.0K)
EBT (Pre-Tax Income)(44.3M)(66.3M)(71.4M)(64.4M)(26.1M)
Income Tax Expense(847.0K)(1.5M)(9.4M)(13.7M)(3.7M)
Bottom Line
Net Income(43.5M)(64.8M)(62.0M)(50.6M)(22.3M)
Earnings from Cont. Ops(43.5M)(64.8M)(62.0M)(50.6M)(22.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(43.5M)(64.8M)(62.0M)(50.6M)(22.3M)
Per Share
Basic EPS($0.34)($0.57)($0.61)($0.51)($0.26)
Diluted EPS($0.34)($0.57)($0.61)($0.51)($0.26)
Revenue Per Share$0.31$0.16$0.26$0.34$0.69
Shares
Basic Shares Outstanding129.3M113.6M102.4M99.7M85.3M
Diluted Shares Outstanding129.3M113.6M102.4M99.7M85.3M
Profitability Metrics
EBITDA(21.6M)(44.5M)(47.8M)(44.9M)(7.8M)
D&A22.8M21.8M23.6M19.5M18.2M
EBIT(44.3M)(66.3M)(71.4M)(64.4M)(26.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026